A review of glucosamine is presented in the November edition of the Drug & Therapeutics Bulletin and concludes that glucosamine at a dose of 1500mg daily probably provides modest symptom relief in patients with osteoarthritis (OA) of the knee and its efficacy appears to be similar to that of NSAIDs.
However they also feel that further trials are needed to clarify its optimal role in the management of the condition. In addition there is currently little evidence on its use for OA at other sites and evidence that it slows disease progression is limited to 2 studies assessing radiological findings.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!